Navigation Links
Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm
Date:3/20/2008

SAN DIEGO, March 20 /PRNewswire/ -- Valor Medical, an emerging medical device company in San Diego, CA, announced today that the first human implant of Neucrylate AN for treatment of cerebral aneurysms was performed by Dr. Sean Pakbaz at the University of Tehran. The treatment was under the guidance of a clinical protocol that had been approved by the University's Internal Ethics Committee.

Dr. Pakbaz stated that the patient's aneurysm was a type and location that is very difficult to treat. However, the insertion of the Neucrylate AN was very smooth and the total procedure time was significantly less than if the procedure had been done with a stent and coils. "The procedure went very well. The many practice implants I performed at Valor's simulated anatomical training lab prepared me for this trial. Valor's technology will make a major impact on how cerebral aneurysms are treated."

Valor Medical's Neucrylate AN is injected into the cerebral aneurysm through a micro-infusion catheter that is first inserted in the femoral artery. Neucrylate AN is a liquid that, when it comes in contact with blood, changes into a solid spongy material. The liquid enables the surgeon to totally fill the aneurysm regardless of shape, a property that is not found with implantable coils.

A cerebral aneurysm is a swelling of an artery in the brain. As the swelling increases the blood-vessel wall weakens and can rupture, causing bleeding and death. It is estimated that over 30,000 patients in the U.S. are diagnosed with cerebral aneurysms each year, and approximately 5 million individuals are walking around in the U.S. with undiagnosed cerebral aneurysms.


'/>"/>
SOURCE Valor Medical
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit
2. ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
3. Data Demonstrate that Obagi Medical Products Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures
4. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
5. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
6. Physicians Will Benefit from Medical Software Advice Website
7. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
8. Vanderbilt Medical Center Seeks Middle Tennesseans with Type 2 Diabetes Who are Overweight for National Clinical Trial
9. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
10. Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities
11. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
Breaking Medicine News(10 mins):